Infectious Diseases (all articles)
Pursuing COVID ‘herd immunity’ without a vaccine could be dangerous & unethical, WHO warns
13 Oct, 2020 | 01:16h | UTC
Review: Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19
13 Oct, 2020 | 01:12h | UTC
[Preprint] Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
13 Oct, 2020 | 01:08h | UTC
Commentary on Twitter
Anyone think we prescribe too many #antibiotics in #COVID19?
Looking for ways to prescribe less?
Well, our latest *PREPRINT* (not peer reviewed!) may be of interest. #antibioticstewardship https://t.co/qUimnZhwg7 Thread (1/7) pic.twitter.com/Z6gaGMgduv— Gabriele Pollara (@gpollara) October 12, 2020
Study: Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
13 Oct, 2020 | 01:10h | UTC
Commentary on Twitter
👨⚕️ Researchers from @HKUniversity test a set of metallodrugs and related compounds, and identify ranitidine bismuth citrate, a commonly used drug for the treatment of Helicobacter pylori #infection, as a potent anti-#SARS-CoV-2 agent.
👁️ Full article https://t.co/Oz5O7hL9js pic.twitter.com/izMRdRTT27
— Immunology of Infectious Disease News (@infdisease_news) October 12, 2020
Outcomes of neonates born to mothers with SARS-CoV-2 Infection
13 Oct, 2020 | 01:05h | UTCEditorial: Balancing Risks in the Time of COVID-19
Commentary: Very low risk to newborns from moms with COVID-19, finds study – Columbia University Irving Medical Center
Excess deaths from Covid-19 and other causes in the US
13 Oct, 2020 | 01:06h | UTCExcess Deaths From COVID-19 and Other Causes, March-July 2020 – JAMA
Editorials: Excess Deaths and the Great Pandemic of 2020 AND The Toll of COVID-19
Video: Excess Deaths During the Coronavirus Pandemic
Related Research: COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries – JAMA AND Mental Health Disorders Related to COVID-19–Related Deaths – JAMA
The effect of temperature on persistence of SARS-CoV-2 on common surfaces
13 Oct, 2020 | 01:04h | UTCThe effect of temperature on persistence of SARS-CoV-2 on common surfaces – Virology Journal
Commentaries: Study: Covid-19 Coronavirus May Survive For 28 Days On These Surfaces – Forbes AND Covid virus ‘survives for 28 days’ in lab conditions – BBC
‘Long Covid’: Why are some people not recovering?
13 Oct, 2020 | 01:03h | UTC‘Long Covid’: Why are some people not recovering? – BBC
Infecting volunteers with coronavirus may be one way to test potential vaccines. But there are risks.
13 Oct, 2020 | 01:02h | UTC
The end of dengue fever? Mosquito experiment in Indonesia sees huge reduction in cases
13 Oct, 2020 | 00:59h | UTC
Cohort study: ‘COVID-19 free’ hospital areas linked to improved outcomes in elective cancer surgery
12 Oct, 2020 | 00:48h | UTCCommentary: ‘COVID-19 free’ hospital areas could save lives after surgery, global study finds – University of Birmingham
Study: Three quarters of people with SARS-CoV-2 infection were asymptomatic the day they took the test
12 Oct, 2020 | 00:46h | UTCCommentaries: Covid: more than 80% of positive UK cases in study had no core symptoms – The Guardian AND Symptoms of COVID-19 are a poor marker of infection, new UK population study shows – Taylor & Francis Group AND Expert reaction to analysis of asymptomatic SARS-CoV-2 infection from English Household Survey data – Science Media Centre
Opinion: Continual lockdowns are not the answer to bringing Covid under control
12 Oct, 2020 | 00:42h | UTCContinual lockdowns are not the answer to bringing Covid under control – The Guardian
Review: Characteristics of SARS-CoV-2 and COVID-19
12 Oct, 2020 | 00:49h | UTCCharacteristics of SARS-CoV-2 and COVID-19 – Nature Reviews Microbiology
Commentary on Twitter
Characteristics of SARS-CoV-2 and COVID-19
Zheng-Li Shi et al. summarize the exceptional amount of research that has characterized SARS-CoV-2 and COVID-19, discussing the emergence and virology of SARS-CoV-2 and the pathogenesis and treatment of COVID-19https://t.co/kGL6nOdOYu pic.twitter.com/1ePqHvLxFz
— Nature Reviews Microbiology (@NatureRevMicro) October 6, 2020
Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset
12 Oct, 2020 | 00:44h | UTCCommentary: Even Mild Covid-19 Infections Can Make People Sick for Months – Bloomberg
Commentary on Twitter
Follow-up of adults with non-critical COVID-19 two months after symptoms' onset – Clinical Microbiology and Infection Two thirds of adults with non-critical COVID-19 had persistent symptoms up to 2 months after symptom onset. https://t.co/xZk2DURyTG
— Carlos del Rio (@CarlosdelRio7) October 10, 2020
New test detects coronavirus in just 5 minutes
12 Oct, 2020 | 00:39h | UTCNew test detects coronavirus in just 5 minutes – Science
Researchers face hurdles to evaluate, synthesize COVID-19 evidence at top speed
12 Oct, 2020 | 00:37h | UTCResearchers face hurdles to evaluate, synthesize COVID-19 evidence at top speed – Science
Opinion: Schools aren’t super-spreaders
12 Oct, 2020 | 00:40h | UTCSchools Aren’t Super-Spreaders – Atlantic
CDC Study: Factors influencing risk for COVID-19 exposure among young adults aged 18–23 years
12 Oct, 2020 | 00:36h | UTC
Commentary on Twitter
Young adults have several factors influencing their risk of being exposed to #COVID19, including perceived low severity of disease outcome and exposure to conflicting messages about the need for and effectiveness of masks, according to new @CDCMMWR. https://t.co/1mNNDrbLCi pic.twitter.com/8hf2F70bZH
— CDC (@CDCgov) October 9, 2020
Transmission dynamics by age group in COVID-19 hotspots in US
12 Oct, 2020 | 00:35h | UTC
Commentary on Twitter
A @CDCMMWR finds percentage of positive #COVID19 tests in hotspot counties went up first in younger adults, then in older adults who may be at higher risk. The report highlights the need to reduce the spread of #COVID19 among younger adults. More: https://t.co/MnHYfZzY7c pic.twitter.com/Y6WaZbB6MH
— MMWR (@CDCMMWR) October 9, 2020
RECOVERY trial: Effect of hydroxychloroquine in hospitalized patients with Covid-19
9 Oct, 2020 | 09:15h | UTC
Less is more: Critically ill status is not a carte blanche for unlimited antibiotic use
12 Oct, 2020 | 00:32h | UTC
Remdesivir for the treatment of Covid-19 — final report
9 Oct, 2020 | 09:13h | UTCRemdesivir for the Treatment of Covid-19 — Final Report – New England Journal of Medicine
Commentary: BREAKING NEWS: Final remdesivir results published after 139 days of waiting – Brief19
Commentary on Twitter
📍Remdesivir trial (ACTT-1) final results finally out.
📍Still no mortality benefit. A study with tons of patients could show some small mortality benefit.
📍Those who recover, do so a bit faster.
📍Not the game-changer that was hyped.via @Brief_19https://t.co/jWRJypJIuS
— Jeremy Faust MD MS (ER physician) (@jeremyfaust) October 8, 2020
[News release – not published yet] Eli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19
9 Oct, 2020 | 09:09h | UTCEli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19 – STAT
Perspective – Coronavirus: Is the cure worse than the disease? The most divisive question of 2020
9 Oct, 2020 | 09:06h | UTC